Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching Expanded Global CDMO Operations

Tanvex BioPharma, Inc.  (“Tanvex”), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars product...

January 20, 2025 | Monday | News
Silexion Therapeutics Reveals Synergistic Efficacy of SIL-204 in Combination with Chemotherapy for Pancreatic Cancer

Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNA...

January 17, 2025 | Friday | News
Vertex Pharmaceuticals and Zai Lab Announce Exclusive Collaboration for Development and Commercialization of Povetacicept in Asia

-Vertex Pharmaceuticals Incorporated  and Zai Lab Limited announced an exclusive collaboration and license agreement for the development a...

January 13, 2025 | Monday | News
Zai Lab and MediLink Forge Global Partnership to Develop Groundbreaking LRRC15 ADC Therapy

Zai Lab Limited announced a new strategic collaboration and worldwide license agreement with MediLink Therapeutics (Suzhou) Co., Ltd.  to use MediLi...

January 13, 2025 | Monday | News
Global Proteomics Breakthrough: UK Biobank and Thermo Fisher to Decode Disease

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker...

January 13, 2025 | Monday | News
Danaher Partners with Innovaccer to Advance Precision Medicine with AI-Enabled Diagnostics

Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions. Investment aligns with Danaher's mission ...

January 10, 2025 | Friday | News
Nona Biosciences Announces BeiGene's Acquisition of Global Rights to a Groundbreaking ADC from DualityBio Collaboration

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM),  announced that BeiGene. Ltd. has ex...

January 03, 2025 | Friday | News
AusperBio Therapeutics Secures $73M Series B Funding to Advance Targeted Therapies for Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

December 27, 2024 | Friday | News
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Precision Medicine and Gene Synthesis for 2025

In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advanc...

December 12, 2024 | Thursday | Interaction
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Partner to Advance Groundbreaking ALS Therapy

- Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to address the underlying patholo...

December 05, 2024 | Thursday | News
Gilead Sciences Partners with Tubulis to Develop Next-Generation Antibody-Drug Conjugate for Solid Tumors

Gilead Sciences, Inc. (Nasdaq: GILD) and Tubulis announced that they have entered into an exclusive option and license agreement to discover...

December 04, 2024 | Wednesday | News
U.S. Bioscience Economy: A Catalyst for Innovation, Economic Growth, and Global Leadership

  The bioscience economy in the United States has evolved into a critical driver of innovation, economic growth, and soci...

December 03, 2024 | Tuesday | Reports
Agilent Drives Strategic Transformation with Strong FY2024 Results, CEO Padraig McDonnell Leads Restructuring for Market Agility and Growth

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, has released its financial results for ...

November 26, 2024 | Tuesday | Company results
Zevra Therapeutics Launches MIPLYFFA™, the First FDA-Approved Treatment for Niemann-Pick Disease Type C

MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is available at Zevra’s specialty pharmacy for dispense AmplifyAssist&...

November 22, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close